Eastern Cooperative Oncology Group clinical trials
Listed in the registry as: Research network.
The registry lists 175 studies whose lead sponsor is Eastern Cooperative Oncology Group. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2026.
Keep track of what changes. Save the Eastern Cooperative Oncology Group studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Eastern Cooperative Oncology Group leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 175. Browse all 175 →
- Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLRecruitingNCT05289687Phase 2
- Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyRecruitingNCT06724237Phase 3
- The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical TrialsRecruitingNCT06756607Not applicable
- Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney FailureRecruitingNCT07085728Phase 2
- A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)Not yet recruitingNCT07122492Not applicable
- Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion ProtocolNot yet recruitingNCT06786585
- Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial TreatmentNot yet recruitingNCT05628623Phase 2
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade GliomaActive, not recruitingNCT00978458Phase 3
- COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) ParticipationTerminatedNCT05076266
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell LymphomaActive, not recruitingNCT01415752Phase 2
- Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003809Phase 3
- Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's LymphomaCompletedNCT00075946Phase 3
- Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00062010Phase 2
- Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell CarcinomaCompletedNCT00068393Phase 2
- Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00042939Phase 2
- Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory AnemiaCompletedNCT00046930Phase 3
- Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00057876Phase 3
- Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic LeukemiaTerminatedNCT00003910Phase 2
- AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsCompletedNCT00427349Phase 2
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00057837Phase 2
- Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the LiverCompletedNCT00003907Phase 2
- Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00098787Phase 2
- Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryCompletedNCT00700882Phase 2
- Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System LymphomaTerminatedNCT00335140Phase 2
- Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedNCT00551759Phase 2
- Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT00101283Phase 2
- Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00096174Phase 2
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLLCompletedNCT00074282Phase 2
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's LymphomaCompletedNCT00003389Phase 3
- Carboplatin Combined With Paclitaxel in Treating Patients With Advanced ThymomaCompletedNCT00010257Phase 2
- Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell LymphomaTerminatedNCT00070291Phase 2
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's MacroglobulinemiaTerminatedNCT00060346Phase 2
- PEG-Interferon Alfa-2b in Treating Patients With Stage IV MelanomaCompletedNCT00049530Phase 2
- Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal CancerCompletedNCT00063986Phase 2
- Sorafenib in Treating Patients With Refractory Non-Small Cell Lung CancerCompletedNCT00064350Phase 2
- Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic SyndromesCompletedNCT00003138Phase 3
- Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's LymphomaCompletedNCT00274924Phase 2
- Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung CancerCompletedNCT00080938Phase 2
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01242800Not applicable
- Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck CancerCompletedNCT00089297Phase 2
- Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing ChemotherapyCompletedNCT01079780Phase 2
- Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal CancerCompletedNCT00033657Phase 2
- Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic MelanomaCompletedNCT00071981Phase 2
- Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung CancerCompletedNCT00103207Phase 2
- Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx CancerCompletedNCT01084083Phase 2
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesCompletedNCT00045305Phase 2
- Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaTerminatedNCT00057954Phase 2
- Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the GroinCompletedNCT00003444Phase 3
- Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic MelanomaCompletedNCT00003027Phase 3
- Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00003376Phase 3